| 7:00 – 7:50 am | Registration, Continental Breakfast and Exhibitor Showcase |
| Morning Sessions | |
| 7:50 – 8:00 am | Welcome and Opening Remarks Michael Gonyeau, PharmD, Interim Dean of the School of Pharmacy and Pharmaceutical Sciences, and John Devlin, PharmD, Associate Scientist, Division of Pulmonary and Critical Care Medicine. |
| 8:00 – 9:00 | 2025 SCCM Pain, Agitation, Delirium, Immobility and Sleep Disruption Practice Guideline Update |
| 8:00 – 8:30 | Sedative Choice: The Role of Dexmedetomidine vs. Alternative Agents Joanna Stollings, PharmD, Vanderbilt University Medical Center, Nashville, TN |
| 8:30 – 9:00 | Pharmacologic Sleep Improvement: The Role of Melatonin Analogs Gerald Weinhouse, MD, Brigham and Women’s Hospital, Boston, MA |
| 9:00 – 10:00 | Generative Artificial Intelligence: Will it Improve ICU Care? Raja-Elie Abdulnour, MD, Brigham and Women’s Hospital, Boston, MA |
| 10:00 –10:30 | Break |
| 10:30 – 10:30 | MORNING PEARLS (10 PGY-2 Critical Care Residents) |
| 10:30 – 11:15 | Pharmacologic Controversies in Rapid Sequence Intubation Edward A. Bittner MD, PhD, MSEd, FCCM, Associate Professor of Anaesthesia, Harvard Medical School; Associate Director, Surgical Intensive Care Unit, Massachusetts General Hospital, Boston, MA |
| 11:15 – 11:45 | Treatment of Hyperglycemic Crises: A 2025 ADA Guideline Update Oussayma Moukhachen, PharmD, BCPS, BCCCP, Massachusetts College of Pharmacy and Health Sciences, Boston, MA and Mt. Auburn Hospital, Cambridge, MA |
| 11:45 – 12:15 | Management of Anxiety in the ICU Maureen K. Cassady, MD, Brigham and Women’s Hospital, Boston, MA BCPS, Director, Clinical Pharmacy Services, Brigham and Women’s Hospital, Boston, MA |
| 12:15 – 1:15 | Lunch and Exhibitor Showcase |
| Afternoon Sessions | |
| 1:15 – 2:15 | Current ARDS Controversies: Ventilator Strategies, Sedation Management and Neuromuscular Blocker Use/Monitoring Rachel Winner, PharmD, and Rachel Putnam, MD, Brigham and Women’s Hospital, Boston, MA |
| 2:15 –2:45 | Anticoagulant Reversal: Current Controversies Andrew Webb, PharmD, Massachusetts General Hospital, Boston, MA |
| 2:45- 3:00 | Break |
| 3:00 – 3:30 | AFTERNOON PEARLS (7 PGY-2 Critical Care Residents) |
| 3:30 – 4:00 | Interpretation of ICU Studies Employing Causal Analysis/Target Trial Emulation Ting Ting Wu, PharmD, PhD, Harvard Pilgrim Healthcare Institute, Boston, MA |
| 4:00 – 4:15 | PROGRAM Wrap Up |